Calendario de promoción JW (Cayman) Therapeutics Co. Ltd
Horario avanzado
gráfico sencillo
Acerca de la empresa
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. más detalles| EBITDA | -0.3143 |
|---|---|
| EV/EBITDA | 0.5634 |
| Industry | Biotechnology |
| P/BV | 1.82 |
| P/S | 164.53 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | cny |
| Выручка | 0.0055 |
| Сайт | https://www.jwtherapeutics.com |
| Цена ао | 0.255 |
| Число акций ао | 0.41153 млрд |
| Cambio de precio por día: | +0.3717% (0.1614) |
|---|---|
| Cambio de precio por semana.: | -4.59% (0.1698) |
| Cambio de precio por mes: | -36.47% (0.255) |
| Cambio de precio en 3 meses.: | -20.59% (0.204) |
| Cambio de precio en seis meses: | -43.16% (0.285) |
| Cambio de precio por año: | -39.37% (0.2672) |
| Cambio de precio en 3 años.: | -88.98% (1.47) |
| Cambio de precio en 5 años.: | -0% (0.162) |
| Cambio de precio en 10 años.: | -0% (0.162) |
| Cambio de precio desde principios de año.: | -4.59% (0.1698) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| DFA Emerging Markets Small Cap Series | 467500 | 0.11 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 336309 | 0.08 |
| DFA Emerging Markets Core Equity Portfolio | 98500 | 0.02 |
| Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF | 95500 | 0.02 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF | 76500 | 0.02 |
| Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF | 69500 | 0.02 |
| DFA Investment Dimensions-World Ex U.S. Core Equity Port | 55500 | 0.01 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 42350 | 0.01 |
| DFA Investment Dimensions-DFA Emerging Markets Targeted Value Port | 38000 | 0.01 |
| Avantis Emerging Markets Equity ETF | 36000 | 0.01 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Dr. Yiping Li M.D. | Co-Founder & Interim Chairman | 836.74k | 1964 (61 año) |
| Cao Xiaoping Ph.D. | Senior Vice President of Tech Operations | N/A | |
| Dr. Shaun Paul Cordoba Ph.D. | Senior VP & Chief Scientific Officer | N/A | 1980 (45 años) |
| Mr. Raymond J. Hage Jr. | Senior Vice President of Corporate Development | N/A | 1968 (57 años) |
| Mr. Mark J. Gilbert M.D. | Senior Advisor & Acting Chief Medical Officer | N/A | |
| Ms. Ka Man Ng A.C.I.S., A.C.S. | Company Secretary | N/A | 1978 (47 años) |
| Mr. Qiang Ma | Senior VP & Chief Commercial Officer | N/A | 1978 (47 años) |
| Ms. Yun Qin | Senior Vice President of Clinical Sciences & Medical Services | N/A | 1982 (43 año) |
| Dr. Su Yang | Senior Vice President Of Clinical Research & PMO | N/A | 1979 (46 años) |
| Mr. Min Liu | CEO & Executive Director | 1973 (52 año) |
DIRECCIÓN: China, Shanghai, Building B - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.jwtherapeutics.com
Sitio web: https://www.jwtherapeutics.com
